| Name | Timtraxanib |
|---|
| Description | Timtraxanib (AVI-3207) is a selective VEGF-2 inhibitor. Timtraxanib can be used for the research of senile macular degeneration[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGF-2[1] |
| In Vitro | Timtraxanib (AVI-3207) is a selective VEGF-2 inhibitor[1]. |
| References |
[1]. Avixgen secured 4 Clinical Pipelines … “Expansion of AIDS Clinical Trial to USA” |
| Molecular Formula | C28H43N7O9 |
|---|---|
| Molecular Weight | 621.68 |